Current Opinion in Pharmacology

Papers
(The H4-Index of Current Opinion in Pharmacology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?104
Editorial Board94
Splice-switching as cancer therapy92
Therapeutic hurdles in acute myeloid leukemia: Leukemic stem cells, inflammation and immune dysfunction69
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies62
The role of extracellular ATP in homeostatic immune cell migration59
From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling50
Recent advances in emerging PCOS therapies49
Lipid raft disruption as an opportunity for peripheral analgesia47
Gastrointestinal issue: Advances in gastrointestinal oncology42
Editorial Board40
Technological advancements to study cellular signaling pathways in inherited retinal degenerative diseases38
Optofluidic neural interfaces for in vivo photopharmacology37
Optic nerve regeneration: Potential treatment approaches35
Photo-isomerizable tweezers to probe ionotropic receptor mechanisms35
Artemisinins and their impact on inhibitory neurotransmission34
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis33
Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma33
Advanced microneedle arrays for transdermal antibiotic delivery32
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance32
Editorial overview: Special issue on “Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases”31
A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury30
Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration30
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus29
Three-dimensional culture models to study glioblastoma — current trends and future perspectives29
Allogeneic double-negative T-cell therapy for acute myeloid leukemia27
Editorial Board27
Paeoniflorin is a promising natural monomer for neurodegenerative diseases via modulation of Ca2+ and ROS homeostasis27
0.068295955657959